The Activation of FGFR1/FRS2 Pathway and the Interaction with EGFR Pathway in Low-Grade Osteosarcoma

被引：0
|
作者：
Peng, Ran [1 ]
Xie, You [1 ]
Jing, Wenyi [1 ]
Qiu, Yan [1 ]
He, Xin [1 ]
Lu, Yang [1 ]
Zhang, Hongying [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
63
引用
收藏
页码：S70 / S71
页数：2
相关论文
共 50 条
  • [1] Amplification of FRS2 and Activation of FGFR/FRS2 Signaling Pathway in High-Grade Liposarcoma
    Zhang, Keqiang
    Chu, Kevin
    Wu, Xiwei
    Gao, Hanlin
    Wang, Jinhui
    Yuan, Yate-Ching
    Loera, Sofia
    Ho, Kimberley
    Wang, Yafan
    Chow, Warren
    Un, Frank
    Chu, Peiguo
    Yen, Yun
    CANCER RESEARCH, 2013, 73 (04) : 1298 - 1307
  • [2] The Role of FGFR/FRS2 Pathway and Its Interaction with EGFR Pathway in Atypical Lipomatous Tumor/Well-differentiated Liposarcoma and Dedifferentiated Liposarcoma
    Peng, Ran
    Jing, Wenyi
    Lu, Yang
    He, Xin
    Zhang, Yahan
    Chen, Min
    Zhang, Hongying
    LABORATORY INVESTIGATION, 2023, 103 (03) : S64 - S65
  • [3] Fibroblast growth factor receptor 1 (FGFR1) tyrosine phosphorylation regulates binding of FGFR substrate 2α (FRS2α) but not FRS2β to the receptor
    Zhang, Yongyou
    McKeehan, Kerstin
    Lin, Yongshun
    Zhang, Jue
    Wang, Fen
    MOLECULAR ENDOCRINOLOGY, 2008, 22 (01) : 167 - 175
  • [4] Ureteric Morphogenesis Requires Fgfr1 and Fgfr2/Frs2α Signaling in the Metanephric Mesenchyme
    Sims-Lucas, Sunder
    Di Giovanni, Valeria
    Schaefer, Caitlin
    Cusack, Brian
    Eswarakumar, Veraragavan P.
    Bates, Carlton M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (04): : 607 - 617
  • [5] The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
    Ho, Thai H.
    Liu, Xian-De
    Huang, Yanqing
    Warneke, Carla L.
    Johnson, Marcella M.
    Hoang, Anh
    Tamboli, Pheroze
    Wang, Fen
    Jonasch, Eric
    BMC CANCER, 2015, 15
  • [6] Consistent Amplification of FRS2 and MDM2 in Low-grade Osteosarcoma A Genetic Study of 22 Cases With Clinicopathologic Analysis
    He, Xin
    Pang, Zongguo
    Zhang, Xianliang
    Lan, Ting
    Chen, Huijiao
    Chen, Min
    Yang, Hong
    Huang, Juan
    Chen, Yihua
    Zhang, Zhang
    Jing, Wenyi
    Peng, Ran
    Zhang, Hongying
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (09) : 1143 - 1155
  • [7] The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
    Thai H Ho
    Xian-De Liu
    Yanqing Huang
    Carla L Warneke
    Marcella M Johnson
    Anh Hoang
    Pheroze Tamboli
    Fen Wang
    Eric Jonasch
    BMC Cancer, 15
  • [8] Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 during mouse development
    Hoch, RV
    Soriano, P
    DEVELOPMENT, 2006, 133 (04): : 663 - 673
  • [9] Interactome of FGFR1 mutations found in low-grade gliomas (LGGs)
    Han, HyeRim
    Jin-Wong, Cassandra
    Gayden, Tenzin
    Hesketh, Geoffrey
    Slattery, Michael
    Jabado, Nada
    Foulkes, William D.
    Gingras, Anne-Claude
    Rivera, Barbara
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 395 - 395
  • [10] EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2
    Wu, YJ
    Chen, ZJ
    Ullrich, A
    BIOLOGICAL CHEMISTRY, 2003, 384 (08) : 1215 - 1226
12345